Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation.
Nacev BA, Dabas Y, Paul MR, Pacheco C, Mitchener M, Perez Y, Fang Y, Soshnev AA, Barrows D, Carroll T, Socci ND, St Jean SC, Tiwari S, Gruss MJ, Monette S, Tap WD, Garcia BA, Muir T, Allis CD.
Nacev BA, et al. Among authors: monette s.
Nat Commun. 2024 Jun 17;15(1):5155. doi: 10.1038/s41467-024-49486-5.
Nat Commun. 2024.
PMID: 38886411
Free PMC article.